Inhibition of cancer cell growth by ruthenium(II) arene complexes

Journal of Medicinal Chemistry

Volumn 44, Issue 22, 2001, Pages 3616-3621

  Morris, R E ^a   Aird, R E ^b   Del Socorro Murdoch, P ^a   Chen, H ^a   Cummings, J ^b   Hughes, N D ^a   Parsons, S ^a   Parkin, A ^a   Boyd, G ^b   Jodrell, D I ^b   Sadler, P J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CHLORIDE ION; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETHYLENEDIAMINE; HALIDE; ISONICOTINAMIDE; OLIGONUCLEOTIDE; RUTHENIUM COMPLEX;

ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; GEOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS;

ANTINEOPLASTIC AGENTS; CRYSTALLOGRAPHY, X-RAY; DNA ADDUCTS; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; MOLECULAR STRUCTURE; OLIGONUCLEOTIDES; ORGANOMETALLIC COMPOUNDS; RUTHENIUM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0035950152     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010051m     Document Type: Article

References (28)

1. Non-platinum chemotherapeutic metallopharmaceuticals
2. Oncological implications of the chemistry of ruthenium
3. New ruthenium complexes for the treatment of cancer
4. Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes
5. 2O
6. Treatment of metastases of solid mouse tumours by NAMI-A: Comparison with cisplatin, cyclophosphamide and dacarbazine
7. Binding of ruthenium(III) antitumor drugs to human lactoferrin probed by high resolution X-ray crystallographic structure analyses
8. 4(DMSO)(Ind)] with apotransferrin: A spectroscopic study
9. Effects of hypoxia and transferrin on toxicity and DNA binding of ruthenium antitumor agents in HeLa cells
10. Organometallic half-sandwich complexes promote the formation of linear oligopeptides from amino acid esters
11. 6-arene-ruthenium(II) complexes of α-amino acids with coordinating side chains
12. 6-polycyclic aromatic)diruthenium(II,II) complexes and their two-electron reduction to cyclohexadienyl anion complexes
13. 2
14. Structural transition in polyphenyls. III. Crystal structure of biphenyl at 110 K
15. Aquo chemistry of monoarene complexes of osmium(II) and ruthenium(II)
16. II complexes of adenosine and guanosine 5′-mono-, -di-and -tri-phosphates
17. 4 with the nucleotides GpA, d(GpA), ApG, d(ApG) and d(CCTGGTCC): High-field NMR characterization of the reaction products
18. Two antitumour ruthenium(III) complexes showing selectivity in their binding towards poly(dG) poly(dC) and poly(dA) poly(dT)
19. Antitumor trans platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt iminoether complex and the deoxy decamer d(CCTCGCTCTC)-d(GAGAGCGAGG)
20. DNA topoisomerases
21. DNA topoisomerases
22. Biochemistry of topoisomerase-I and topoisomerase-II inhibition by anthracenyl-amino acid conjugates
23. Inhibition of topoisomerase II catalytic activity by two ruthenium compounds: A ligand-dependent mode of action
24. Arene ruthenium(II) complexes formed by dehydrogenation of cyclohexadienes with ruthenium(III) trichloride
25. Benzene complexes of ruthenium(II)
26. + salts
27. Preparation of arene ruthenium(II) complexes with activated ligands for protein labeling
28. Development of anthracenyl-amino acid conjugates as topoisomerase I and II inhibitors that circumvent drug resistance